Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 36.32
+2.17 (6.35%)
At close: Mar 27, 2026
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 14.51 billion as of March 27, 2026. Its market cap has increased by 84.09% in one year.
Market Cap
14.51B
Enterprise Value
15.76B
Revenue
662.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.32
Market Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 14.51B, an increase of 48.17%. That is a compound annual growth rate of 9.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 14.51B | -5.59% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
| Jan 18, 2022 | 9.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 16.90B |
| Inner Mongolia Furui Medical Science | 15.08B |
| Jinyu Bio-technology | 14.93B |
| Anhui Anke Biotechnology (Group) | 14.72B |
| Vcanbio Cell & Gene Engineering Corp., | 14.03B |
| Tibet Cheezheng Tibetan Medicine | 12.64B |
| Pacific Shuanglin Bio-pharmacy | 12.36B |
| Chengzhi | 12.18B |